PHYTOCHEMICAL PROFILING OF GUDUCHI (TINOSPORA CORDIFOLIA): LINKING AYURVEDIC PERSPECTIVES TO MOLECULAR MECHANISMS OF INFLAMMATION: A NARRATIVE REVIEW

Abstract

Tinospora cordifolia (Willd.) Hook. f. & Thomson, commonly known in Ayurveda as Guduchi or Amrita, is a renowned Rasayana medicinal plant traditionally valued for its Shothahara (anti-inflammatory), Jwarahara (antipyretic), and immunomodulatory properties. This review integrates phytochemical data curated from the IMPPAT database and verified using PubChem with evidence from published pharmacological studies to evaluate the extent to which these classical therapeutic attributes can be explained in molecular terms. The major bioactive constituents examined include the alkaloids berberine, magnoflorine, and palmatine; the diterpenoid lactones tinosporide, cordifolide, and columbin; the glycosides cordifolioside A and syringin; arabinogalactan polysaccharides; and the phytosterols β-sitosterol and stigmasterol. These phytoconstituents have been investigated for their reported ability to modulate key inflammatory signaling pathways, including NF-κB, MAPK, JAK-STAT, the NLRP3 inflammasome, and the COX-2/LOX axis. Collectively, the available evidence indicates that Guduchi exerts its anti-inflammatory effects through the coordinated regulation of multiple interconnected molecular pathways rather than a single pharmacological target. This multitarget mode of action provides a scientifically plausible explanation for its classical Ayurvedic designation as a Tridoshahara, Shothahara, and Rasayana drug. However, the majority of current evidence is derived from preclinical investigations, while robust, well-designed clinical trials remain limited. A database-informed, literature-validated approach such as this offers a reproducible framework for bridging traditional Ayurvedic pharmacology with contemporary molecular pharmacology and drug discovery, while also highlighting critical gaps requiring further mechanistic and clinical investigation.